
    
      Approximately individuals with type 2 diabetes will be randomized in a 1:1 ratio to treatment
      groups. Classes will occur online. Participants will be evaluated at 0, 16, and 32 weeks. Our
      main outcome of interest is HbA1c (glycated hemoglobin, a measure indicative of blood glucose
      levels and tied to diabetes severity).
    
  